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OBJECTIVES: The red blood cell distribution width has been associated with an increased risk of cardiovascular
events. In the present study, we assessed the relationship between red cell distribution width values and cardiac
troponin I levels in patients admitted with non-ST-elevation acute coronary syndrome.
METHODS: We analyzed blood parameters in 251 adult patients who were consecutively admitted to the
intensive coronary care unit with non-ST-elevation acute coronary syndrome over a 1-year period. For all
patients, a baseline blood sample was collected for routine hematological testing. Cardiac troponin I was
measured at baseline and after 6 h. The patients were diagnosed with non-ST-elevation myocardial infarction
or unstable angina based on the elevation of cardiac troponin I levels.
RESULTS: The red cell distribution width was higher in the group with non-ST-elevation myocardial infarction
compared with the patient group with unstable angina (14.6¡1.0 vs 13.06¡1.7, respectively; p=0.006).
Coronary thrombus was detected more frequently in the group of patients with non-ST-elevation myocardial
infarction than in the patients with unstable angina (72% vs 51%, respectively; p=0.007). Using receiver
operating characteristic curve analysis for the prediction of non-ST-elevation myocardial infarction based on
the red cell distribution width, the area under the curve was 0.649 (95% confidence interval: 0.546-0.753;
p= 0.006), suggesting a modest model for the prediction of non-ST-elevation myocardial infarction using the
red cell distribution width. At a cut-off value of 14%, the sensitivity and specificity of the red cell distribution
width were 73% and 59%, respectively. Additionally, the red cell distribution width was positively correlated
with cardiac troponin I (r = 0.19; p= 0.006).
CONCLUSION: A greater baseline red cell distribution width value was associated with myocardial injury and
elevated cardiac troponin I levels in non-ST-elevation acute coronary syndrome. Therefore, the red cell
distribution width could be considered for risk stratification of acute coronary syndrome patients admitted to
emergency departments.
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& INTRODUCTION
Cardiac troponin I (cTnI) is the preferred biomarker for
predicting not only short-term (30 days) but also long-term
(1 year and beyond) outcomes with respect to myocardial
infarction (MI) and death (1,2). Elevated troponin levels are
associated with increased risk and are additive to other risk
factors, such as electrocardiography (ECG) changes and
markers of inflammatory activity (3). The red cell distribu-
tion width (RDW) has also been proposed as an indepen-
dent predictor. It has been reported that the diagnostic
accuracy of troponins within 2-4 h of symptom onset is
limited due to the specific kinetics of this protein in the
injured myocardium (4). The identification of patients with
elevated troponin levels is especially useful for selecting the
appropriate treatment in patients with non-ST-elevation
acute coronary syndrome (NSTE-ACS).
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The RDW is a measure of the heterogeneity of red blood
cell size obtained from red blood cell size distribution
curves. This parameter has been shown to be predictive of
morbidity and mortality in various cardiovascular diseases,
such as heart failure, stable coronary artery disease and
acute myocardial infarction (AMI) (5,6). The RDW has also
been proposed as an independent predictor of mortality in
non-ST-elevation MI (NSTEMI) (7). In the present study, our
aim was to investigate the relationship between the RDW
and cTnI in patients with NSTE-ACS.
& METHODS
A total of 251 consecutive patients were hospitalized in
our hospital with a diagnosis of NSTE-ACS. Acute coronary
syndrome (ACS) was defined as presentation with symp-
toms of ischemia in association with ECG changes (ST
segment deviation, T-wave inversion and new Q-wave),
positive cardiac enzymes, new documentation of CAD, or a
previous diagnosis of CAD, as defined by similar previous
studies (8). Symptomatic patients were assessed using a
standard diagnostic flowchart that included clinical and
ECG monitoring as well as biochemical measurements of
markers of myocardial necrosis. Patients who were diag-
nosed with NSTEMI or unstable angina (UA) according to
elevation of cTnI levels were included in this study. The
study protocol was approved by the institutional review
board at our center, and written informed consent was
obtained from all patients. Demographic characteristics;
medical histories; laboratory studies, including white blood
cell (WBC) counts peripheral differential counts; and a
variety of hospital outcomes data were collected. Clinical
information was obtained regarding the patients’ history of
systemic hypertension (HTN); diabetes mellitus (DM);
dyslipidemia; smoking; and previous CAD, including
coronary angioplasty or myocardial revascularization and
a family history of premature CAD. Venous blood was
collected for blood parameter assessment after admission to
the intensive care unit. At our hospital, blood samples are
collected from the antecubital vein by an atraumatic
puncture and are sent to the laboratory for analysis within
1 h after collection. Venous blood was collected in a tube
containing K3 EDTA for measurement of hematologic
indices and for baseline determination of cTnI levels in all
patients. Hemoglobin (Hb), the RDW and the WBC count
were also measured as part of the automated complete
blood count using a Coulter LH 780 Hematology Analyzer
(Beckman Coulter Ireland Inc., Mervue, Galway, Ireland).
The normal reference range for the RDW in our laboratory is
11.5 to 14.0%. Because of the known association between
anemia and adverse cardiovascular events, we performed
additional analyses in the population of patients who were
not anemic on presentation in an attempt to determine
whether the predictive power of the RDWwas either related
to or affected by baseline Hb levels. Using the WHO
definition of anemia (Hb,13 g/dl), there were a total of 184
patients who were classified as non-anemic. Patients with a
history of trauma, surgery, neoplasm, or infectious disease
in the last 30 days prior to hospitalization, as well as those
currently using immunosuppressants (including corticos-
teroids) and prior aspirin users were excluded. cTnI levels
were assessed using a chemiluminescent immunoenzymatic
assay (Access AccuTnI, Beckman Coulter, Fullerton, CA,
USA). The detection limit of this assay is 0.01 ng/ml and the
99th percentile in an apparently healthy reference popula-
tion is reported to be 0.04 ng/ml. To confirm or rule out the
presence of NSTEMI, cTnI measurement was repeated after
6 h. Additionally, transthoracic echocardiography was
performed on each patient after admission to the intensive
cardiac care unit. All measurements were performed using a
commercially available machine (Vivid 7, GE Healthcare,
Horten, Norway) with a 3.5-MHz transducer. The Simpson
method was used in the 2-dimensional echocardiographic
apical 4-chamber view to assess the left ventricular ejection
fraction (LVEF). Coronary angiographies were also per-
formed in our clinic using the standard Judkins technique
24 h after hospital admission.
Statistical analysis
Continuous variables are expressed as the mean¡SD.
Categorical variables are expressed as percentages.
Student’s t-test or analysis of variance was used to compare
parametric continuous variables. The Mann-Whitney U-test
or the Kruskal-Wallis test was used to compare nonpara-
metric continuous variables. To compare categorical vari-
ables, the x2-test was used. Relationships between variables
were examined using Pearson’s correlation coefficient.
Receiver operating characteristic (ROC) curves for RDW
values were plotted to determine the optimal cut-off values
for individual parameters in order to predict NSTEMI and
to establish the optimal cut-off points for use in clinical
decision-making. Multivariate logistic regression analysis
was also used to identify the independent predictors of
NSTEMI in patients with chest pain. All variables showing
significance values of less than 0.1 in the univariate analysis
(total cholesterol, LDL-C, cTnI, ischemic ECG changes,
aspirin use, LVEF, RDW, coronary thrombus, neutrophil
count, multiarterial CAD, neutrophil/lymphocyte ratio and
WBC count) were included in the model. Two-tailed p-
values of less than 0.05 were considered to indicate
statistical significance. All statistical analyses were per-
formed using the SPSS program (version 20.0; SPSS Inc.,
Chicago, IL, USA).
& RESULTS
A total of 184 patients constituted the study population.
The baseline clinical, laboratory and angiographic charac-
teristics of the study population, stratified by cTnI values,
are shown in Tables 1 and 2. Based on the troponin values,
the patients were classified as having NSTEMI if at least one
cTnI value was increased above the 99th percentile URL;
otherwise, UA was diagnosed. The participants in the group
of patients with NSTEMI had significantly higher total
cholesterol and LDL-C levels. Additionally, the LVEF was
significantly lower in the group with NSTEMI compared
with the group with UA. In contrast, the neutrophil count
and the NLR were significantly higher in the group of
patients with NSTEMI. Moreover, ischemic ECG changes
were more prevalent in the group with NSTEMI compared
with the group with UA (p= 0.001) and coronary thrombus
was reported more frequently in the group with NSTEMI
compared with the group with UA (72% vs 51%, respec-
tively; p= 0.007).
The RDWwas higher in the groupwithNSTEMI compared
with the patient group with UA (14.6¡1.0% vs 13.06¡1.7%,
respectively; p,0.001). When we analyzed the patient
characteristics according to the classification stratified by
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the cut-off RDW value ($14.0% vs ,14.0%), we found that
patients with higher RDW values were older and had higher
LDL-C and cTnI values, a lower LVEF, a greater total number
of diseased coronary arteries and lowerMCH values than the
patients with lower RDW values did (Table 3).
In the correlation analyses, the RDW was positively
correlated with LDL-C (r = 0.21; p= 0.012) and cTnI (r = 0.19;
p= 0.045) levels (Figure 1). Conversely, the RDW was
negatively correlated with the LVEF (r = -0.26; p= 0.0032).
Additionally, the RDW was significantly correlated with the
WBC count (r = 0.18; p= 0.041) and the total number of
diseased coronary arteries (r = 0.25; p= 0.003). In the multi-
variate analysis, multiarterial coronary disease, the WBC
count, the neutrophil/lymphocyte ratio, ischemic ECG
changes, the RDW, the neutrophil count and a history of
CABG were independently correlated with NSTEMI in the
patients admitted to the hospital with chest pain (Table 4).
Regarding the diagnostic accuracy of the RDW, we
calculated the composite score for sensitivity and specificity
(i.e., the area under the curve (AUC)), as determined by the
ROC curve analysis for the prediction of NSTEMI by the
RDW. Overall, the AUC was 0.649 (95% confidence interval:
0.546-0.753; p,0.01), suggesting a modest model for the
prediction of NSTEMI using the RDW. Using a cut-off value
of 14.05%, the sensitivity and specificity of the RDW were
73% and 56%, respectively (Figure 2).
& DISCUSSION
The principal finding of our study was that the RDW
might predict increased myocardial injury in patients with
NSTE-ACS. In particular, in the study group, the degree of
myocardial dysfunction (based on the LVEF) and the levels
of inflammatory mediators in the blood were associated
with RDW values. Our study especially demonstrates an
important relationship between RDW and increased cTnI
levels in patients with NSTE-ACS.
The RDW has been reported to be a predictor of coronary
heart disease events in different cardiovascular conditions
and of all-cause mortality (9,10). In a study by Cavusoglu et
al., the RDW was also found to be a strong independent
predictor of all-cause mortality in the ACS subset of patients
based on a multivariate analysis (11). In a study by Sandip et
al. (12), a greater CAD risk category was associated with a
linear increase in the RDW value, suggesting that the RDW
is a potent predictor of CAD risk. In another study, Tonelli
et al. (13) reported that among patients with CAD and
without heart failure, mortality rates were significantly
increased in patients with elevated RDW values compared
with patients with RDW values within the normal range.
Chronic subclinical inflammation appears to be a poten-
tial pathophysiologic mechanism underlying the association
between the RDW and CAD and other cardiovascular
events (14). Inflammation leads to anisocytosis due to the
release of immature red blood cells into the peripheral
circulation. The association between inflammation and an
increased RDW is supported by findings of increased levels
of CRP, interleukin-6 and soluble tumor necrosis factor
receptors 1 and 2 in patients with elevated RDW values
(15,16). In our study, we found that indicators of inflamma-
tion such as the total leukocyte count and the neutrophil
count were significantly correlated with higher RDW
values. In addition to these markers, the neutrophil/
lymphocyte ratio and thrombus formation in diseased
coronaries were significantly associated with higher RDW
values.
Another mechanism suggested to underlie the association
between the RDW and an increased frequency of CAD
events is oxidative stress. High oxidative stress has been
shown to be associated with an increased risk of cardiovas-
cular events (17). Additionally, high oxidative stress reduces
red blood cell survival, causes anisocytosis and promotes
the release of premature red blood cells into the peripheral
circulation (18).
In a study by Lippi et al. (19), researchers investigated the
role of the RDW in patients with chest pain suggestive of
ACS. These researchers reported that the combined mea-
surement of cardiac troponin and the RDW at admission
increased the already impressive sensitivity of cardiac
troponin from 94% to 99% in diagnosing ACS. In another
Table 1 - Baseline characteristics of the study population, stratified according to the final diagnosis of the study
patients.
Variable UA NSTEMI p
Gender (M/F), n 50/33 59/42 0.79
Age (years) 56.2¡10.8 58.6¡12.2 0.68
HT, n (%) 34 (41%) 40 (39%) 0.98
DM (%) 19 (23%) 16 (15%) 0.39
Total cholesterol (mg/dl) 184¡62 204¡45 0.067
LDL cholesterol (mg/dl) 106¡41 134¡43 0.002
Smoking history, n (%) 42 (51%) 50 (50%) 0.78
Previous PCI, n (%) 15 (18%) 13 (13%) 0.52
Previous CABG, n (%) 1 (2%) 0 (0%) 0.35
LVEF (%) 55.6¡8.5 50.3¡9.6 0.001
Diseased coronary arteries (n) (1 vessel)/(.1 vessel) 38/45 38/63 0.09
Coronary thrombus (%) 51% 72% 0.007
Presence of ischemic ECG changes (%) 53% 81% 0.001
Table 2 - Blood parameters of the study population,
stratified according to cardiac troponin I elevation.
Variable UA NSTEMI p
Blood hemoglobin (g/dl) 14.4¡0.9 14.7¡2.6 0.95
White blood cell count (103/ml) 9.1¡2.8 9.8¡2.4 0.055
Neutrophil count (103/ml) 5.88¡1.92 6.8¡1.79 0.001
Lymphocyte count (103/ml) 1.98¡0.65 1.95¡0.67 0.92
Neutrophil/lymphocyte ratio 3.25¡1.32 3.95¡1.91 0.032
Platelet count (6109/l) 229.9¡49.5 239.8¡70.4 0.98
MPV (fl) 8.41¡0.94 8.53¡0.95 0.35
MCV (m3) 89.4¡3.6 88.6¡8.9 0.36
RDW (%) 13.06¡1.7 14.6¡1.0 0.006
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Table 3 - Baseline characteristics of the entire cohort, stratified by the upper tertile of the baseline RDW values
($14.05% vs ,14.05%).
Characteristic RDW,14.05% (n=103) RDW$14.05% (n=81) p
Gender (M/F), n 71/32 51/30 0.78
Age (years) 55.1¡11.8 61.4¡11.1 0.004
UA, n (%) 29 (37%) 11 (18%) 0.042
NSTEMI, n (%) 49 (62%) 50 (81%) 0.046
HT, n (%) 27 (34%) 29 (48%) 0.12
DM (%) 17 (22%) 8 (14%) 0.19
Total cholesterol (mg/dl) 193¡47 206¡55 0.18
LDL cholesterol (mg/dl) 119¡46 135¡40 0.022
Smoking history, n (%) 40 (51%) 31 (50%) 0.95
Previous PCI, n (%) 11 (18%) 9 (13%) 0.56
Previous CABG, n (%) 1 (1.3%) 1 (1.6%) 0.68
LVEF (%) 54.6¡8.3 49.3¡9.6 0.007
Diseased coronary (n) (1 vessel)/(.1 vessel) 50/53 25/56 0.011
Coronary thrombus (%) 65% 67% 0.82
Ischemic ECG changes (%) 73% 73% 1.00
Blood hemoglobin (g/dl) 14.8¡1.9 14.3¡1.0 0.95
White blood cell count (103/ml) 9.4¡2.6 9.9¡2.5 0.055
Neutrophil count (103/ml) 6.15¡1.91 6.56¡1.74 0.001
Lymphocyte count (103/ml) 1.97¡0.65 1.94¡0.69 0.92
Neutrophil/lymphocyte ratio 3.75¡1.94 3.77¡1.60 0.065
Platelet count (6109/l) 236.8¡65.7 238.2¡65.3 0.98
MPV (fl) 8.49¡1.02 8.51¡0.83 0.35
MCV (m3) 89.03¡9.10 90.25¡5.91 0.36
Figure 1 - Correlation between RDW and the cardiac troponin values (r = 0.19; p=0.045).
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study, by Cemin et al. (20), investigators studied the
relationship between red blood cells, platelet morphology
and AMI and also assessed whether they could supplement
the role of traditional cardiac biomarkers in the early
identification of patients with AMI. The researchers found
that the RDW predicted AMI with statistical significance
only in female patients. In our study, we found that among
the clinical variables, ischemic ECG findings, LDL-C levels,
coronary thrombus and a history of CABG were significant
predictors of cardiac troponin increase in the patients with
NSTE-ACS. Among the hematologic parameters, the WBC
count and the RDW were significant predictors of increased
cardiac troponin levels. The RDW is thus a simple and
economical laboratory measurement that has relatively
good diagnostic accuracy in predicting NSTEMI in patients
with NSTE-ACS. Considering the fact that the specific
kinetics of troponin in the injured myocardium limit its
usefulness within 2-4 h of symptom onset, baseline RDW
measurement seems helpful for predicting myocardial
injury at an earlier time point. We suggest that the RDW
should be considered along with conventional cardiac
markers for the prediction of NSTEMI in patients with
NSTE-ACS and should serve as a guide for making
appropriate treatment decisions.
Limitations
The main limitations of our study were the small number
of study groups, the single-center design and inclusion
limited to patients admitted to the intensive care unit.
Because our study thus represents a very specific popula-
tion, the results cannot be generalized. Increased RDW
values are noted in clinical settings such as hemolysis;
Table 4 - Independent predictors of NSTEMI in a multivariate logistic regression analysis.
Variables Multivariate OR (95% CI) p-value
LDL cholesterol 2.633 (1.183-5.864) 0.020
Neutrophil count (103/ml) 2.796 (1.561-4.770) 0.038
RDW 3.164 (1.423-7.033) 0.004
Coronary thrombus 2.294 (1.074-4.902) 0.032
Ischemic ECG changes 0.246 (0.110-0.549) 0.01
Previous CABG 3.605 (2.751-4.724) 0.018
LVEF 1.231 (0.999-1.517) 0.132
Multiarterial coronary artery disease (.1 vessel) 0.50 (0.08-2.46) 0.3
Neutrophil/lymphocyte ratio 1.06 (0.82-1.08) 0.06
White blood cell count 1.32 (0.86-2.02) 0.07
CI: confidence interval; OR: odds ratio.
Figure 2 - Receiver operating characteristic (ROC) curve analysis for prediction of NSTEMI by red blood cell distribution width (RDW).
The area under the curve (AUC) is 0.649 (95% confidence interval: 0.546-0.753; p,0.001) for RDW.
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increased red cell destruction after blood transfusion; and
ineffective red cell production, such as during iron, vitamin
B12, or folate deficiency. The RDW can also be increased in
clinical conditions such as pregnancy, thrombotic thrombo-
cytopenic purpura and inflammatory diseases (21-23). Only
Hb levels were measured in the present study, whereas
parameters such as iron, vitamin B12 and folate were not
assessed. None of our patients received blood transfusion
and no pregnant women or individuals with inflammatory
diseases, thrombotic thrombocytopenic purpura, or malnu-
trition were included.
A greater baseline RDW value is associated with
myocardial injury; therefore, the RDW could be considered
as an additional marker for evaluating patients with NSTE-
ACS. RDW is also a widely available marker that, in contrast
to other novel markers of cardiovascular risk, can be
obtained at no additional cost.
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